Skip to content
Agentic OS
Menu

Intelligence / Healthtech / PMA Approvals / Contego Medical, INC.

Approvalsdevice change approved (PMA)4 Nov 2026

Contego Medical, INC.

4 Nov 2026: Device change approved (PMA) · Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection. Recorded in the openFDA device PMA data.

View the source record

Decided
4 Nov 2026
Device
Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
Specialty
Cardiovascular
Type
Supplement (Panel Track)
Reason
Change Design/Components/Specifications/Material
Reference
P240009 S006
Location
Raleigh, NC
What this signal means

A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.

  1. Cardiovascular leads with 53 of 120, then Pathology (15).
  2. 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Contego Medical, INC.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Contego Medical, INC. in our registers.

More in Cardiovascular

PMA Approvals

See all

Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.